Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Medifast Inc (MED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,872,946
  • Shares Outstanding, K 11,970
  • Annual Sales, $ 301,560 K
  • Annual Income, $ 27,720 K
  • 36-Month Beta 0.54
  • Price/Sales 6.43
  • Price/Cash Flow 59.26
  • Price/Book 17.35

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 1.19
  • Number of Estimates 1
  • High Estimate 1.19
  • Low Estimate 1.19
  • Prior Year 0.60
  • Growth Rate Est. (year over year) +98.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
148.00 +7.38%
on 11/08/18
219.99 -27.76%
on 10/31/18
-48.68 (-23.45%)
since 10/15/18
3-Month
148.00 +7.38%
on 11/08/18
260.98 -39.11%
on 09/13/18
-49.93 (-23.91%)
since 08/15/18
52-Week
61.96 +156.49%
on 03/01/18
260.98 -39.11%
on 09/13/18
+92.08 (+137.76%)
since 11/15/17

Most Recent Stories

More News
Medifast, Inc. Completes $10 Million Stock Repurchase

Medifast, Inc. (NYSE: MED), a leading manufacturer and distributor of clinically proven, healthy living products and programs, today announced it has completed a $10 million stock repurchase. This repurchase...

MED : 158.92 (+1.57%)
After Yesterday's Rally of 1.55% Shares Could Potentially Pullback

Medifast Inc (NYSE:MED) traded in a range yesterday that spanned from a low of $153.79 to a high of $160.41. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $160.41...

MED : 158.92 (+1.57%)
Medifast Inc Has Returned 28.2% Since SmarTrend Recommendation (MED)

SmarTrend identified a Downtrend for Medifast Inc (NYSE:MED) on September 19th, 2018 at $215.65. In approximately 2 months, Medifast Inc has returned 28.20% as of today's recent price of $154.84.

MED : 158.92 (+1.57%)
Look for Shares of Medifast Inc to Potentially Rebound after Yesterday's 24.54% Sell Off

Medifast Inc (NYSE:MED) traded in a range yesterday that spanned from a low of $158.29 to a high of $177.94. Yesterday, the shares fell 24.5%, which took the trading range below the 3-day low of $205.62...

MED : 158.92 (+1.57%)
Medifast (MED) Misses Q3 Earnings Estimates

Medifast (MED) delivered earnings and revenue surprises of -0.87% and 11.04%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

MED : 158.92 (+1.57%)
Medifast: 3Q Earnings Snapshot

BALTIMORE (AP) _ Medifast Inc. (MED) on Tuesday reported third-quarter profit of $13.8 million.

MED : 158.92 (+1.57%)
Medifast, Inc. Announces Third Quarter 2018 Financial Results

Medifast, Inc. (NYSE: MED), a leading manufacturer and distributor of clinically proven, healthy living products and programs, today reported financial results for the third quarter ended September 30,...

MED : 158.92 (+1.57%)
Estimize Roundtable: How much longer can the US consumer hold up? Plus Q3 and holiday shopping predictions for retailers

This week on the Estimize Roundtable, Estimize’s CEO, Leigh Drogen and SVP of Media, Christine Short, are joined by Jeff Macke, head of Macke Asset Management, and we are excited to welcome a new guest,...

TGT : 80.76 (-2.85%)
JWN : 58.99 (-3.45%)
ULTA : 311.81 (-0.42%)
FL : 51.40 (+0.47%)
BBBY : 13.33 (-2.20%)
GOOS : 68.22 (+5.85%)
M : 32.27 (-2.86%)
MED : 158.92 (+1.57%)
MCD : 183.56 (-0.16%)
LULU : 139.83 (-0.21%)
UAA : 22.39 (-0.84%)
LOW : 93.68 (-1.30%)
RH : 119.40 (-3.60%)
LB : 35.69 (-3.10%)
JCP : 1.36 (+11.48%)
ANF : 17.53 (-1.52%)
HD : 177.36 (-1.41%)
CROC : 51.63 (-1.36%)
AMZN : 1,619.44 (+1.28%)
ELF : 13.20 (+2.40%)
WMT : 99.54 (-1.96%)
Medifast (MED) Outpaces Stock Market Gains: What You Should Know

Medifast (MED) closed the most recent trading day at $214.20, moving +1.19% from the previous trading session.

MED : 158.92 (+1.57%)
Medifast (MED) Q3 Earnings: Coaches & OPTAVIA are Key Drivers

Medifast's (MED) Q3 performance to gain from a sturdy coach base and advancement in the OPTAVIA brand.

TPB : 34.70 (+4.90%)
NUS : 68.02 (+2.18%)
MED : 158.92 (+1.57%)
HAIN : 22.57 (+1.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade MED with:

Business Summary

Medifast is a leading manufacturer and distributor of clinically proven healthy living products and programs. It is the brand recommended by more than 20,000 Doctors. Medifast produces, distributes, and sells weight loss and other health-related products through websites, multi-level marketing, telemarketing,...

See More

Key Turning Points

2nd Resistance Point 164.13
1st Resistance Point 161.52
Last Price 158.92
1st Support Level 154.20
2nd Support Level 149.49

See More

52-Week High 260.98
Fibonacci 61.8% 184.95
Fibonacci 50% 161.47
Last Price 158.92
Fibonacci 38.2% 137.99
52-Week Low 61.96

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar